BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20816973)

  • 21. Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis.
    Kanegane H; Yang X; Zhao M; Yamato K; Inoue M; Hamamoto K; Kobayashi C; Hosono A; Ito Y; Nakazawa Y; Terui K; Kogawa K; Ishii E; Sumazaki R; Miyawaki T
    Pediatr Allergy Immunol; 2012 Aug; 23(5):488-93. PubMed ID: 22433061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical phenotype and functional analysis of a rare XIAP/BIRC4 mutation.
    Vieth S; Ammann S; Schwarz K; Härtel C; Schultz C; Lehmberg K; Lauten M
    Klin Padiatr; 2013 Nov; 225(6):343-6. PubMed ID: 24166087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
    Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
    Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.
    Speckmann C; Lehmberg K; Albert MH; Damgaard RB; Fritsch M; Gyrd-Hansen M; Rensing-Ehl A; Vraetz T; Grimbacher B; Salzer U; Fuchs I; Ufheil H; Belohradsky BH; Hassan A; Cale CM; Elawad M; Strahm B; Schibli S; Lauten M; Kohl M; Meerpohl JJ; Rodeck B; Kolb R; Eberl W; Soerensen J; von Bernuth H; Lorenz M; Schwarz K; Zur Stadt U; Ehl S
    Clin Immunol; 2013 Oct; 149(1):133-41. PubMed ID: 23973892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
    Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
    [No Abstract]   [Full Text] [Related]  

  • 26. Natural killer T cells and X-linked lymphoproliferative syndrome.
    Latour S
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):510-4. PubMed ID: 17989527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haploidentical Hematopoietic Stem Cell Transplantation for XIAP Deficiency: a Single-Center Report.
    Yang J; Zhu GH; Wang B; Zhang R; Jia CG; Yan Y; Ma HH; Qin MQ
    J Clin Immunol; 2020 Aug; 40(6):893-900. PubMed ID: 32627096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-linked lymphoproliferative syndromes and related autosomal recessive disorders.
    Veillette A; Pérez-Quintero LA; Latour S
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):614-22. PubMed ID: 24113228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
    Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.
    Rezaei N; Mahmoudi E; Aghamohammadi A; Das R; Nichols KE
    Br J Haematol; 2011 Jan; 152(1):13-30. PubMed ID: 21083659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysgammaglobulinemia Associated With Glu349del, a Hypomorphic XIAP Mutation.
    Nishida N; Yang X; Takasaki I; Imai K; Kato K; Inoue Y; Imamura T; Miyashita R; Kato F; Yamaide A; Mori M; Saito S; Hara J; Adachi Y; Miyawaki T; Kanegane H
    J Investig Allergol Clin Immunol; 2015; 25(3):205-13. PubMed ID: 26182687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XIAP deficiency syndrome in humans.
    Latour S; Aguilar C
    Semin Cell Dev Biol; 2015 Mar; 39():115-23. PubMed ID: 25666262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
    Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG
    PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP.
    Hare NJ; Ma CS; Alvaro F; Nichols KE; Tangye SG
    Int Immunol; 2006 Jul; 18(7):1055-65. PubMed ID: 16720617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
    Aguilar C; Latour S
    J Clin Immunol; 2015 May; 35(4):331-8. PubMed ID: 25737324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
    Booth C; Gilmour KC; Veys P; Gennery AR; Slatter MA; Chapel H; Heath PT; Steward CG; Smith O; O'Meara A; Kerrigan H; Mahlaoui N; Cavazzana-Calvo M; Fischer A; Moshous D; Blanche S; Pachlopnik Schmid J; Latour S; de Saint-Basile G; Albert M; Notheis G; Rieber N; Strahm B; Ritterbusch H; Lankester A; Hartwig NG; Meyts I; Plebani A; Soresina A; Finocchi A; Pignata C; Cirillo E; Bonanomi S; Peters C; Kalwak K; Pasic S; Sedlacek P; Jazbec J; Kanegane H; Nichols KE; Hanson IC; Kapoor N; Haddad E; Cowan M; Choo S; Smart J; Arkwright PD; Gaspar HB
    Blood; 2011 Jan; 117(1):53-62. PubMed ID: 20926771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-linked lymphoproliferative syndromes: brothers or distant cousins?
    Filipovich AH; Zhang K; Snow AL; Marsh RA
    Blood; 2010 Nov; 116(18):3398-408. PubMed ID: 20660790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential pathogenic mechanism of type 1 X-linked lymphoproliferative syndrome caused by a mutation of SH2D1A gene in an infant: A case report.
    Wang Y; Wang Y; Lu W; Tao L; Xiao Y; Zhou Y; He X; Zhang Y; Li L
    Medicine (Baltimore); 2022 Oct; 101(41):e30951. PubMed ID: 36254040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2.
    Yang X; Wada T; Imadome K; Nishida N; Mukai T; Fujiwara M; Kawashima H; Kato F; Fujiwara S; Yachie A; Zhao X; Miyawaki T; Kanegane H
    Herpesviridae; 2012 Feb; 3(1):1. PubMed ID: 22325832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
    Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
    BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.